Genetic predisposition testing for breast cancer

Cancer Journal from Scientific American

Volumn 2, Issue 5, 1996, Pages 244-249

  Schulman, Joseph D ^a   Stern, Harvey J ^b  

^a GENETICS AND IVF INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; METHODOLOGY; MUTATION; RISK ASSESSMENT; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MUTATION; RISK ASSESSMENT;

EID: 0343083778     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Kolata G. Breaking ranks, lab offers test assessing cancer risk. The New York Times, April 1, 1996.
2. Szabo CI, King M-C. Inherited breast and ovarian cancer. Hum Mol Genet 1995;4:1811-1817.
3. Schildkraut JM, Risch N, Thompson WD. Evaluating genetic association among ovarian, breast and endometrial cancer: evidence for a breast/ovarian cancer relationship. Am J Hum Genet 1989;45:521-529.
4. Futrel PA, Liu Q, Shattuck-Eidens D et al. BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994;266: 120-122.
5. Sporn MB. Review article: the war on cancer. Lancet 1996;347: 1377-1381.
6. Brown MS, Goldstein JL. Heart attacks: gone with the century [editorial]? Science 1996;272:629.
7. Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-823.
8. Friend SH, Dryja TP, Weinberg RA. Oncogenes and tumor supressor genes. N Engl J Med 1988;318:618-622.
9. Newman B, Austin MA, Lee M, King M-C. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 1988;85: 3044-3048.
10. King M-C, Rowell SE, Love SM. Inherited breast and ovarian cancer: what are the risks? What are the choices? J Am Med Assoc 1993;269:1975-1980.
11. Hall JM, Lee MK, Newman B et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250:1684-1689.
12. Easton DF, Bishop DT, Ford D et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:678-701.
13. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
14. Wooster R, Neuhausen SL, Magion J et al. Localization of a breast cancer susceptibility gene, BRCA2 to chromosome 13q12-13. Science 1994;265:2088-2090.
15. Friend SH. Breast cancer susceptibility testing: realities in the post genomic era. Nature Genet 1996;13:16-17.
16. Weber BL. Science and Medicine: Genetic testing for breast cancer. Scientific American 1996;12-21.
17. Struewing JP, Tarone RE, Brody LC, Li FP, Boice JD. BRCA1 mutations in young women with breast cancer. Lancet 1996; 347:1493.
18. Wagner TMU, Möslinger R, Zielinski C, Scheiner O, Breiteneder H. New Austrian mutation in BRCA1 gene detected in three unrelated HBOC families. Lancet 1996;347:1263-1264.
19. Collins FS. BRCA1 - Lots of mutations, lots of dilemmas [editorial]. N Engl J Med 1996;334:186-188.
20. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA. BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 1996; 334: 137-142.
21. Fitzgerald MG, MacDonald DJ, Krainer M et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 1996;334:143-149.
22. Struewing PJ, Abeliovich D, Peretz, T et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals [letter]. Nature Genet 1996;11:198-200.
23. Goldgar DE, Reilly PR. News and Views: A common BRCA1 mutation in the Ashkenazim. Nature Genet 1995;11:113-114.
24. Motulsky AG. Jewish diseases and origins. Nature Genet 1995; 9:99-100.
25. Sher C, Sharabani-Gargir L, Shohat M. Breast cancer and BRCA1 mutations [letter]. N Eng J Med 1996;334:1199.
26. Berman DB, Wagner-Costalas J, Schultz DC et al,. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet 1996;58:1166-1176.
27. Neuhausen S, Gilewski T, Norton L et al. Recurrent BRCA2 6174deIT mutations in Ashkenazi Jewish women affected by breast cancer. Nature Genet 1996;13:126-128.
28. Haber DA, Garber JE, Finkelstein, DM. Breast cancer and BRCA1 mutations [letter]. N Eng J of Med 1996;334:1199-1200.
29. Koenig B. Gene tests: What you know can hurt you. The New York Times, April 6, 1996.
30. Hubbard R, Lewotin RC. Sounding Board: Pitfalls of genetic testing. N Engl J of Med 1996;334:1192-1193.
31. Sowell T. The vision of the Anointed: Self-Congratulation as a Basis for Social Policy. New York: BasicBooks, 1995.
32. Meyn MS. Letter to the Editor: Assessing gene tests, risk and mastectomy. New York Times, April 10, 1996.
33. Pennisi VR, Capozzi A. Subcutaneous mastectomy: an interim report on 1244 patients. Ann Plast Surg 1984;12:340-347.
34. Kuvshinoff B, Selzer M, Petrek J, Pressman P, Borgen P. Bilateral prophylatic mastectomy in high risk patients [abstract]. Proc Soc Surg Oncol 1995.
35. Study Update: Why is the familial cancer study important? Newsletter of the NIH Study on Familial Cancer in the Jewish Community, March 19, 1996.
36. Wadman M. Women need not apply. The DNA test that doctots don't want to share. The Washington Post, May 5, 1996.
37. Simha JA. Letter to the Editor: Some want to know breast cancer risks. The New York Times, April 8, 1996.
38. Rovner J. Policy and People: US lawmakers address genetic discrimination. Lancet 1996;347:1400.
39. Rosenblatt DS, Foulkes WD, Narod SA. Genetic screening for breast cancer [letter]. N Engl J Med 1996;334:1200-1201.
40. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 1996;14: 1730-1736.
41. Rubin R. Deadly family trees: a new project tracks a high-cholesterol gene that kills early. US News and World Report, January 24, 1994:71-72.
42. Fey R, Pearson N. Statins and coronary heart disease. Lancet 1996;347:1389-1390.
43. MRC Vitamin Study Research Group. Prevention of neural tube defects:results of the medical research council vitamin study. Lancet 1991;338:131-137.
44. Smithells RW, Shephard S, Schorah CJ et al. Possible prevention of neural tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-340.